Abstract

Health systems are recognised as playing a potentially important role in many risk management strategies; however, there is strong evidence that health systems themselves have been the victims of unanticipated risks and have lost their functionality in providing reliable services. Existing risk identification and assessment tools in the health sector, particularly in the blood supply chain, address and evaluate risks without taking into account their interdependence and a holistic perspective. As a result, the aim of this paper is to develop a new systemic framework based on a semi-quantitative risk assessment approach to measure supply chain risks, which will be implemented through a case study on the Iranian BSC. This paper identifies and assesses supply chain risks (SCRs) by employing a novel systemic process known as SSM-SNA-ISM (SSI). First, the supply chain and its risks are identified using Soft Systems Methodology (SSM). Then, given the large number of risks, the second stage uses Social Network Analysis (SNA) to identify the relationships between the risks and select the most important ones. In the third stage, risk levelling is performed with a more in-depth analysis of the selected risks and the application of Interpretive Structural Modelling (ISM), and further analysis is performed using the Cross-Impact Matrix Multiplication Applied to Classification (MICMAC). The study found that by using the new proposed approach, taking into account risk relationships, and taking a holistic view, various supply chain risks could be assessed more effectively, especially when the number of risks is large. The findings also revealed that resolving the root risks of the blood supply chain frequently necessitates management skills. This paper contributes to the literature on supply chain risk management in two ways: First, a novel systemic approach to identifying and evaluating risks is proposed. This process offers a fresh perspective on supply chain risk modelling by utilising systems thinking tools. Second, by identifying Iranian BSC risks and identifying special risks.

Highlights

  • Licensee MDPI, Basel, Switzerland.While the supply chain (SC) concept has attracted interest among academics, policymakers, and companies [1,2,3], its success in any organisation may be compromised by a variety of factors, including high demand volatility, short product life cycles, and varying customer requirements [4,5]

  • By addressing the aforementioned gaps, this study aims to add new theoretical and practical insights to a growing body of knowledge about reducing risks associated with blood supply chains in health systems, in countries where the health sector is becoming increasingly vulnerable to unexpected risks

  • blood SC (BSC) are exposed to a variety of risks in many health systems, and their neglect can

Read more

Summary

Introduction

While the supply chain (SC) concept has attracted interest among academics, policymakers, and companies [1,2,3], its success in any organisation may be compromised by a variety of factors, including high demand volatility, short product life cycles, and varying customer requirements [4,5]. Addressing these issues is difficult due to the complex nature of SCs [6].

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call